- Home
- KRMD vs KTTA Comparison
KRMD vs KTTA Comparison
Compare KRMD & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- KTTA
- Stock Information
- Founded
- KRMD 1980
- KTTA 2020
- Country
- KRMD United States
- KTTA United States
- Employees
- KRMD N/A
- KTTA N/A
- Industry
- KRMD Medical/Dental Instruments
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- KTTA Health Care
- Exchange
- KRMD Nasdaq
- KTTA Nasdaq
- Market Cap
- KRMD 134.3M
- KTTA 5.5M
- IPO Year
- KRMD N/A
- KTTA 2021
- Fundamental
- Price
- KRMD $3.22
- KTTA $0.69
- Analyst Decision
- KRMD Strong Buy
- KTTA
- Analyst Count
- KRMD 4
- KTTA 0
- Target Price
- KRMD $4.63
- KTTA N/A
- AVG Volume (30 Days)
- KRMD 450.7K
- KTTA 136.4K
- Earning Date
- KRMD 08-06-2025
- KTTA 08-12-2025
- Dividend Yield
- KRMD N/A
- KTTA N/A
- EPS Growth
- KRMD N/A
- KTTA N/A
- EPS
- KRMD N/A
- KTTA N/A
- Revenue
- KRMD $35,083,740.00
- KTTA N/A
- Revenue This Year
- KRMD $18.16
- KTTA N/A
- Revenue Next Year
- KRMD $14.60
- KTTA N/A
- P/E Ratio
- KRMD N/A
- KTTA N/A
- Revenue Growth
- KRMD 19.65
- KTTA N/A
- 52 Week Low
- KRMD $1.86
- KTTA $0.67
- 52 Week High
- KRMD $5.05
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- KRMD 42.70
- KTTA 32.71
- Support Level
- KRMD $3.54
- KTTA $0.67
- Resistance Level
- KRMD $3.80
- KTTA $0.77
- Average True Range (ATR)
- KRMD 0.23
- KTTA 0.03
- MACD
- KRMD -0.04
- KTTA 0.01
- Stochastic Oscillator
- KRMD 7.63
- KTTA 22.68
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).